trending Market Intelligence /marketintelligence/en/news-insights/trending/cl_vccdbhqf3gan-tqxt6w2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

CytoDyn appoints board chairman

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


CytoDyn appoints board chairman

CytoDyn Inc. appointed Scott Kelly as board chairman.

Kelly, who has served as a member of the company's board since April 2017, succeeds Anthony Caracciolo, who will continue as a director.

Vancouver, Wash.-based CytoDyn develops humanized monoclonal antibodies to treat and prevent HIV infection.